Home › NDC Lookup › RxCUI directory › RxCUI 1869684

Glutamine 5000 MG Powder for Oral Solution — RxCUI 1869684

RxNorm drug concept · Semantic clinical drug
RxCUI 1869684 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1869684
Official nameGlutamine 5000 MG Powder for Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asl-glutamine 5 GM Powder for Oral Solution; glutamine 5 GM Powder for Oral Solution
FDA products mapped4
Package NDCs mapped4
Reported Medicaid activity (SDUD)2,400 prescriptions · 17 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to L-glutamine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's used to reduce acute complications of sickle cell disease in adults and children 5 and older. It's not a cure, but it's meant to help lower flare-up complications.
  • You take it by mouth twice a day, with the amount based on body weight. Mix it right before taking in a cold or room-temperature drink like water or milk, or in a bit of applesauce...
  • The most common ones are constipation, nausea, headache, stomach pain, cough, and pain in the back, chest, or limbs. Many of these also happen with sickle cell disease. Let me or y...
  • No interaction studies have been done, so we don't have specifics. Please keep your medication list up to date with me so I can check everything you take.
📖 Read our full L-glutamine guide →

🕸️ Concept Web — How Glutamine 5000 MG Powder for Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Glutamine 5000 MG Powder for Oral Solution RxCUI 1869684

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Glutamine 4885
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Endari 1928936
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Glutamine Powder for Oral Solution 1869683
    • Glutamine Oral Powder Product 1869682
    • Glutamine Oral Product 1165838
    • Glutamine Powder for Oral Solution [Endari] 1928938
    • Endari Oral Powder Product 1928940
    • Endari Oral Product 1928939
    • Powder for Oral Solution 1540455
    • Oral Powder Product 1294711
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Glutamine 5000 MG SCDC · 1869681
  • Glutamine Powder for Oral Solution SCDF · 1869683
  • Glutamine Oral Powder Product SCDG · 1869682
  • Glutamine Oral Product SCDG · 1165838

Brand-Name Concepts

  • Glutamine 5000 MG Powder for Oral Solution [Endari] SBD · 1928941
  • Glutamine 5000 MG [Endari] SBDC · 1928937
  • Glutamine Powder for Oral Solution [Endari] SBDF · 1928938
  • Endari Oral Powder Product SBDG · 1928940
  • Endari Oral Product SBDG · 1928939
  • Endari BN · 1928936

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 1869684 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
31722-0483-60 60 PACKET in 1 CARTON (31722-483-60) / 1 POWDER, FOR SOLUTI... L-glutamine Camber Pharmaceuticals, Inc. 2026-05-26
42457-0420-60 60 PACKET in 1 CARTON (42457-420-60) / 1 POWDER, FOR SOLUTI... Endari Emmaus Medical, Inc. 2017-07-07
70954-0417-20 60 PACKET in 1 CARTON (70954-417-20) / 1 POWDER, FOR SOLUTI... L-Glutamine ANI Pharmaceuticals, Inc. 2024-07-11
84897-0057-60 60 PACKET in 1 CARTON (84897-057-60) / 1 POWDER, FOR SOLUTI... L-glutamine Renova Pharmaceuticals LLC 2026-05-19
Observed labelers: ANI Pharmaceuticals, Inc. (1) · Camber Pharmaceuticals, Inc. (1) · Emmaus Medical, Inc. (1) · Renova Pharmaceuticals LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.